Xolremdi Side Effects

Generic name: mavorixafor

Medically reviewed by Drugs.com. Last updated on Dec 10, 2024.

Note: This document provides detailed information about Xolremdi.

Applies to mavorixafor: oral capsules Side Effects associated with mavorixafor. Some dosage forms listed on this page may not apply specifically to the brand name Xolremdi.

Applies to mavorixafor: oral capsules.

Side effects include:

Most common adverse effects (incidence >10% and at a frequency higher than placebo): thrombocytopenia, pityriasis, rash, rhinitis, epistaxis, vomiting, dizziness.

For healthcare professionals

Applies to mavorixafor: oral capsule.

General adverse events

The most common adverse reactions (10% or greater) were: thrombocytopenia, pityriasis, rash, rhinitis, epistaxis, vomiting and dizziness.^[Ref]

Gastrointestinal

• Very common (10% or more): Vomiting (14%)^[Ref]

Dermatologic

• Very common (10% or more): Pityriasis (14%), rash (14%)^[Ref]

Hematologic

• Very common (10% or more): Thrombocytopenia (21%)^[Ref]

Cardiovascular

• Frequency not reported: QTc interval prolongation^[Ref]

Nervous system

• Very common (10% or more): Dizziness (14%)^[Ref]

Respiratory

• Very common (10% or more): Rhinitis (14%), epistaxis (14%)^[Ref]

See also:

Further information

Xolremdi side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.

Medical Disclaimer